Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Karen Buttigieg and Miles Carroll.
Connection Strength

1.205
  1. Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19. Nat Commun. 2021 02 24; 12(1):1260.
    View in: PubMed
    Score: 0.233
  2. Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity. Nat Commun. 2021 01 04; 12(1):81.
    View in: PubMed
    Score: 0.231
  3. Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations. Br J Pharmacol. 2021 02; 178(3):626-635.
    View in: PubMed
    Score: 0.230
  4. Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays. Nat Protoc. 2021 06; 16(6):3114-3140.
    View in: PubMed
    Score: 0.059
  5. Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2. Nat Struct Mol Biol. 2021 Mar; 28(3):326.
    View in: PubMed
    Score: 0.058
  6. A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses. Nat Commun. 2021 01 22; 12(1):542.
    View in: PubMed
    Score: 0.058
  7. Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial. EClinicalMedicine. 2021 Jan; 31:100689.
    View in: PubMed
    Score: 0.058
  8. Author Correction: Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2. Nat Struct Mol Biol. 2020 Nov; 27(11):1094.
    View in: PubMed
    Score: 0.057
  9. A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction. Nat Commun. 2020 08 21; 11(1):4198.
    View in: PubMed
    Score: 0.056
  10. Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient. Nat Struct Mol Biol. 2020 10; 27(10):950-958.
    View in: PubMed
    Score: 0.056
  11. Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2. Nat Struct Mol Biol. 2020 09; 27(9):846-854.
    View in: PubMed
    Score: 0.056
  12. Immunogenicity of a DNA vaccine candidate for COVID-19. Nat Commun. 2020 05 20; 11(1):2601.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.